Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
President Donald Trump met with a group of Fortune 500 CEOs at the White House Monday and warned them that any move to shift manufacturing processes overseas will be met with a "substantial border tax," reports CNN.
The Florida Department of Health on Friday sent an email to pharmacists warning them of potential prescription drug shortages in the state due to recent sanctions taken against the wholesale drug distributor McKesson Corp., reports Pain News Network.
President Donald Trump signed an executive order Monday formally withdrawing the U.S. from the Trans-Pacific Partnership — a trade agreement to lower or eliminate tariffs between the U.S. and 11 other countries, reports NBC News.
The pharmaceutical industry's major lobbying group has launched its largest-ever ad campaign designed to improve the industry's public image following heated criticism over rising drug prices and President Donald Trump's comments in a January press conference, in which he said…
During the JPMorgan Healthcare Conference in San Francisco this month, Business Insider posed a hypothetical question to drug company executives: How would your job be affected if annual — or sometimes biannual — price hikes were not standard practice?
President Donald Trump plans to tackle high drug prices through his ACA replacement, White House press secretary Sean Spicer said during a Monday press briefing.
Northfield, Ill.-based Medline Industries joined forces with San Francisco-based Potrero Medical to expand the commercialization and clinical investigations of the Accuryn critical care monitoring system.
The smart and mobile supply chain solutions market was valued at about $7 billion in 2013 and is expected to rise at a calculated annual growth rate of 13.2 percent from 2014 to 2020, according to a new report from…
The Food and Drug Administration on Thursday approved New York City-based Synergy Pharmaceuticals' drug for chronic idiopathic constipation.
Ethicon Endo-Surgery, a subsidiary of New Brunswick, N.J.–based Johnson & Johnson, acquired Megadyne Medical Products — a Draper, Utah-based medical device company that develops electrosurgical tools.